ArticleCancer medicine2018

Targeting of AKT/ERK/CTNNB1 by DAW22 as a potential therapeutic compound for malignant peripheral nerve sheath tumor.

Xiao-Xiao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.